Creatd (NASDAQ:CRTD) stock is gaining on Wednesday following news of a deal for wellness beverage subsidiary Dune Glow Remedy.
Urban Outfitters said that Dune was the perfect partner it was looking for going into the new season. The company points to the “amazing taste, healthy ingredients that deliver on their promise, and beautiful packaging,” of Dune products as reasons behind its decision to offer it in its stores.
Thomas Punch, the founder of Dune and CEO of Creatd, said the following about the deal boosting CRTD stock higher today.
“We are proud to see Dune, and Creatd Ventures’ other e-commerce brands, continue to build traction and open up opportunities to further expand our reach through partnerships with such iconic and inspirational lifestyle brands as UO.”
News of the deal with Urban Outfitters also has shares of CRTD stock seeing heavy trading on Wednesday. That has some 45 million shares of the stock on the move as of this writing. To put that in perspective, the company’s daily average trading volume is closer to 514,000 shares.
CRTD stock is up 38.9% as of Wednesday afternoon but is still down 40.9% since the start of the year.
Investors searching for more recent stock market news are in luck!
We’ve got all the hottest stock market coverage that traders need for Wednesday! Among that is what’s happening with shares of Kaleido Biosciences (NASDAQ:KLDO) stock, HighPeak Energy (NASDAQ:HPK) stock, and Sierra Oncology (NASDAQ:SRRA) stock today. You can find out all about these matters by checking out the links below!
More Wednesday Stock Market News
- Dear KLDO Stock Fans, Mark Your Calendars for April 28
- Why Is HighPeak Energy (HPK) Stock Up Today?
- Why Is Sierra Oncology (SRRA) Stock Up Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed